Discovery of new drug platforms

Additionally, we are discovering bispecific small molecules (BSM) and inhibitor drug conjugates (IDC) that are small molecules acting like bispecific antibodies, and antibody drug conjugates (ADC), respectively.
Lead compounds have been discovered, and currently, optimizations are in progress.
One of example for BSM is the above 3rdgeneration cancer immunotherapy.